애스파이어 바이오파마(ASBP)는 NASDAQ에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $8.98 (-1.54%), 시가총액 $0.01B, 52주 최저~최고 $1.56 ~ $66.30.
Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, such as melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration
애스파이어 바이오파마의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.
애스파이어 바이오파마의 현재 주가는 $8.98 (-1.54%)입니다. BlackAll Trade에서 실시간 시세와 차트를 확인할 수 있습니다.
애스파이어 바이오파마의 시가총액은 약 $0.01B입니다.
Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers sublingua